Clinical Trial Update: Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pegylated interferon, ribavirin, and boceprevir for genotype 1 hepatitis C with cirrhosis awaiting liver transplantation has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Cirrhosis

Drugs mentioned

• Boceprevir (boceprevir)
• Pegylated interferon alfa (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HCV Infection, Liver Cirrhosis, Experimental | Phase 2 | Status: COMPLETED